Dataset Information

COVID-19 mortality effects of underlying health conditions in India: a modelling study

ABSTRACT:

Objective

To model how known COVID-19 comorbidities affect mortality rates and the age distribution of mortality in a large lower-middle-income country (India), and to identify which health conditions drive differences with high-income countries.

Design

Modelling study.

Setting

England and India.

Participants

Individual data were obtained from the fourth round of the District Level Household Survey and Annual Health Survey in India, and aggregate data were obtained from the Health Survey for England and the Global Burden of Disease, Risk Factors and Injuries Studies.

Main outcome measures

The primary outcome was the modelled age-specific mortality in each country due to each COVID-19 mortality risk factor (diabetes, hypertension, obesity and respiratory illness, among others). The change in overall mortality and in the share of deaths under age 60 from the combination of risk factors was estimated in each country.

Results

Relative to England, Indians have higher rates of diabetes (10.6% vs 8.5%) and chronic respiratory disease (4.8% vs 2.5%), and lower rates of obesity (4.4% vs 27.9%), chronic heart disease (4.4% vs 5.9%) and cancer (0.3% vs 2.8%). Population COVID-19 mortality in India, relative to England, is most increased by uncontrolled diabetes (+5.67%) and chronic respiratory disease (+1.88%), and most reduced by obesity (?5.47%), cancer (?3.65%) and chronic heart disease (?1.20%). Comorbidities were associated with a 6.26% lower risk of mortality in India compared with England. Demographics and population health explain a third of the difference in share of deaths under age 60 between the two countries.

Conclusions

Known COVID-19 health risk factors are not expected to have a large effect on mortality or its age distribution in India relative to England. The high share of COVID-19 deaths from people under age 60 in low- and middle-income countries (LMICs) remains unexplained. Understanding the mortality risk associated with health conditions prevalent in LMICs, such as malnutrition and HIV/AIDS, is essential for understanding differential mortality.

SUBMITTER: Novosad P

PROVIDER: S-EPMC7745455 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:Since its outbreak, COVID-19 disease has claimed over one hundred thousand lives in the United States, resulting to multiple and complex nation-wide challenges. In this study, we employ global and local regression models to assess the influence of socio-economic and health conditions on COVID-19 mortality in contiguous USA. For a start, stepwise and exploratory regression models were employed to isolate the main explanatory variables for COVID-19 mortality from the ensemble 33 socio-economic and health parameters between January 1st and 16th of September 2020. Preliminary results showed that only five out of the examined variables (case fatality rate, vulnerable population, poverty, percentage of adults that report no leisure-time physical activity, and percentage of the population with access to places for physical activity) can explain the variability of COVID-19 mortality across the Counties of contiguous USA within the study period. Consequently, we employ three global and two local regression algorithms to model the relationship between COVID-19 and the isolated socio-economic and health variables. The outcomes of the regression analyses show that the adopted models can explain 61%-81% of COVID-19 mortality across the contiguous USA within the study period. However, MGWR yielded the highest R2 (0.81) and lowest AICc values (4031), emphasizing that it is the most efficient among the adopted regression models. The computed average adjusted R2 values show that local regression models (mean adj. R2 = 0.80) outperformed the global regression models (mean adj. R2 = 0.64), indicating that the former is ideal for modeling spatial causal relationships. The GIS-based optimized cluster analyses results show that hotspots for COVID-19 mortality as well as socioeconomic variables are mostly delineated in the South, Mid-West and Northeast of contiguous USA. COVID-19 mortality exhibited positive and significant association with black race (0.51), minority (0.48) and poverty (0.34). Whereas, the percentage of persons that attended college was negatively associated with poverty (-0.51), obesity (-0.50) and diabetes (-0.45). Results show that education is crucial to improve socio-economic and health conditions of the Americans. We conclude that investing in people's standard of living would reduce the vulnerability of an entire population.

Project description:BackgroundThe development and widespread use of an effective SARS-CoV-2 vaccine could prevent substantial morbidity and mortality associated with COVID-19 and mitigate the secondary effects associated with non-pharmaceutical interventions.MethodsWe used an age-structured, expanded SEIR model with social contact matrices to assess age-specific vaccine allocation strategies in India. We used state-specific age structures and disease transmission coefficients estimated from confirmed incident cases of COVID-19 between 1 July and 31 August 2020. Simulations were used to investigate the relative reduction in mortality and morbidity of vaccine allocation strategies based on prioritizing different age groups, and the interactions of these strategies with concurrent non-pharmaceutical interventions. Given the uncertainty associated with COVID-19 vaccine development, we varied vaccine characteristics in the modelling simulations.ResultsPrioritizing COVID-19 vaccine allocation for older populations (i.e., >60 years) led to the greatest relative reduction in deaths, regardless of vaccine efficacy, control measures, rollout speed, or immunity dynamics. Preferential vaccination of this group often produced relatively higher total symptomatic infections and more pronounced estimates of peak incidence than other assessed strategies. Vaccine efficacy, immunity type, target coverage, and rollout speed significantly influenced overall strategy effectiveness, with the time taken to reach target coverage significantly affecting the relative mortality benefit comparative to no vaccination.ConclusionsOur findings support global recommendations to prioritize COVID-19 vaccine allocation for older age groups. Relative differences between allocation strategies were reduced as the speed of vaccine rollout was increased. Optimal vaccine allocation strategies will depend on vaccine characteristics, strength of concurrent non-pharmaceutical interventions, and region-specific goals.

Project description:BackgroundTo date, over 2 million people worldwide have died with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To describe the experience in Ireland, this study examined associations between underlying conditions and the following outcomes: mortality, admission to hospital or admission to the intensive care unit (ICU) among those infected with COVID-19.MethodsThis study used data from the Health Protection Surveillance Centre in Ireland and included confirmed cases of COVID-19 from the first wave of the pandemic between March and July 2020. Two cohorts were included: all cases (community and hospital) and hospital admissions only. For all cases, health outcome data included mortality and hospitalisation. For hospitalised cases, outcome data included mortality and ICU admission. Logistic regression was used to examine associations between underlying conditions and outcomes across both cohorts. Results are presented as adjusted odds ratios (OR) and 95% confidence intervals (CIs).FindingsThere were 19,789 cases included in analysis, which encompassed 1,476 (7.5%) deaths, 2,811 (14.2%) hospitalisations, and 438 (2.2%) ICU admissions of whom 90 (20.5%) died. Significantly higher risk of mortality, hospitalisation and ICU admission was associated with having chronic heart disease, a BMI ≥40kg/m2 and male sex. Additionally, diagnosis of a chronic neurological condition (OR 1.41; 95%CI:1.17, 1.69), chronic kidney disease (OR 1.74; 95%CI:1.35, 2.24) and cancer (OR 2.77; 95%CI:2.21, 3.47) were significantly associated with higher risk of mortality among all cases, with similar patterns of association observed for mortality among hospitalised cases.InterpretationThe identification of underlying conditions among COVID-19 cases may help identify those at highest risk of the worst health outcomes and inform preventive strategies to improve outcomes.FundingThis study was supported by the Health Service Executive, Health Protection Surveillance Centre. KEB and MM are funded by the Health Research Board (RL-15-1579 and EIA-2019-012 respectively).